These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3416557)

  • 1. Creatinine clearance evaluation in routine diabetes practice.
    Guillausseau PJ; Fontbonne A; Cahen-Varsaux J; Moulonguet M; Papoz L; Lubetzki J
    Diabetes Res; 1988 Mar; 7(3):145-8. PubMed ID: 3416557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
    Hoek FJ; Kemperman FA; Krediet RT
    Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients.
    Sanusi AA; Akinsola A; Ajayi AA
    Afr J Med Med Sci; 2000 Mar; 29(1):7-11. PubMed ID: 11379474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in creatinine excretion in adult diabetic, overweight men and women: consequences on creatinine-based classification of renal disease.
    Jacobi D; Lavigne C; Halimi JM; Fierrard H; Andres C; Couet C; Maillot F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):102-7. PubMed ID: 18191268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes.
    Harmoinen AP; Kouri TT; Wirta OR; Lehtimäki TJ; Rantalaiho V; Turjanmaa VM; Pasternack AI
    Clin Nephrol; 1999 Dec; 52(6):363-70. PubMed ID: 10604644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cystatin C improve the precision of Cockcroft and Gault's creatinine clearance estimation?
    Gabutti L; Ferrari N; Mombelli G; Marone C
    J Nephrol; 2004; 17(5):673-8. PubMed ID: 15593034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications.
    Agarwal R
    Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lean body mass-adjusted Cockcroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine.
    Lim WH; Lim EM; McDonald S
    Nephrology (Carlton); 2006 Jun; 11(3):250-6. PubMed ID: 16756641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of measured and estimated creatinine clearance in patients with advanced HIV disease.
    Huang E; Hewitt RG; Shelton M; Morse GD
    Pharmacotherapy; 1996; 16(2):222-9. PubMed ID: 8820465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between four-hour creatinine clearance and 51Cr-EDTA test].
    Peréz E; Ugarte C; Durruty P; Soto MC; Ayca V; Sotomayor G; Soledad Barría M
    Rev Med Chil; 1995 May; 123(5):600-4. PubMed ID: 8525206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cimetidine improves GFR-estimation by the Cockcroft and Gault formula.
    Ixkes MC; Koopman MG; van Acker BA; Weber JA; Arisz L
    Clin Nephrol; 1997 Apr; 47(4):229-36. PubMed ID: 9128789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring renal function in obese patients with type 2 diabetes mellitus in daily practice.
    van de Ree MA; Christiaan G; Huisman MV; van der Vijver JC; Meinders AE
    Diabetes Nutr Metab; 2001 Apr; 14(2):66-70. PubMed ID: 11383675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.
    Rossing P; Rossing K; Gaede P; Pedersen O; Parving HH
    Diabetes Care; 2006 May; 29(5):1024-30. PubMed ID: 16644632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathy: glomerular filtration rate and estimated creatinine clearance].
    Guimarães J; Bastos M; Melo M; Carvalheiro M
    Acta Med Port; 2007; 20(2):145-50. PubMed ID: 17868520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of GFR estimated from plasma creatinine after cimetidine administration in patients with diabetes mellitus type 2.
    Kemperman FA; Silberbusch J; Slaats EH; Prins AM; Krediet RT; Arisz L
    Clin Nephrol; 2000 Oct; 54(4):255-60. PubMed ID: 11076100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
    Rashid ST; Salman M; Agarwal S; Hamilton G
    Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):294-9. PubMed ID: 16716614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
    Apperloo JJ; Gerlag PG; Beerenhout CH; Vader HL
    Ned Tijdschr Geneeskd; 2007 May; 151(18):1016-23. PubMed ID: 17508688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.